To assess the clinical significance of ETNK2 mRNA expression in GC, we first analysed its expression in data sets from institutional cohort, consisting of normal stomach tissues and GC specimens from patients with Stage I, II/III, or IV GC. Here, ETNK2 is linked to gastric cancer.